In addition, it is unclear whether BMT should be performed as consolidation treatment after induction chemotherapy or whether patients should be transplanted immediately after diagnosis of MDS. In this paper, we report our own data of 20 patients with advanced primary MDS which were subjected to ...
Disability-adjusted life year ASDR: Age-standardized DALY rate COPD: Chronic obstructive pulmonary disease CKD: Chronic kidney diseases TMREL: Theoretical minimum risk exposure level ASR: Age-standardized rate CI: Confident interval UI: Uncertainty interval RR: Risk ratio ...
Because of it often being hereditary, first-degree relatives have a 5 to 7-fold higher risk of developing the disease in comparison to the general population [19]. There is no definite cure for this condition. It is, however, possible to treat the symptoms and improve life expectancy [10]...
who had received olaparib for over 4 years, died approximately 1 year and 9 months later. This patient previously was reported to have a SAE of pancytopenia while on study treatment. This was the only case of AML reported in Study 19; two patients were reported with MDS, as described previ...
(95%CI: − 0.088–0.118),p = .78]. Results were robust and low risk of publication bias was detected. No differences were detected based on sub-group analyses comparing medical conditions or risk of bias of studies. Quality of the evidence was rated as moderate over concerns in ...
![Figure 1][1] Figure 1 Conclusion In a prospective study, we observed that int-2 or high risk MDS pts with a HLA-matched donor have an improved life expectancy as compared to pts without donor. This study confirmed that they should be referred to the transplantation before acquisition of...
Complex lifestyle intervention among inactive older adults with elevated cardiovascular disease risk and obesity: a mixed-method, single-arm feasibility study for RESTART- a randomized controlled trial. Pilot Feasibility Stud. 2021;7:190. https://doi.org/10.1186/s40814-021-00921-0. Article Google ...
Stauder R. The challenge of individualised risk assessment and therapy planning in elderly high-risk myelodysplastic syndromes (MDS) patients. Ann Hematol. 2012;91(9):1333–43.Stauder R. The challenge of individualised risk assessment and therapy planning in elderly high-risk myelodysplastic syndromes...
prevention of IFI in high-risk neutropenic patients in Sweden.Given the assumptions, methods, and data used, posaconazole is expected to be cost effective compared with standard azoles when used as antifungal prophylaxis in AML or MDS patients with chemotherapy-induced prolonged neutropenia in Sweden....
2.3. Asian MDS Patients Fall More Frequently into the Intermediate-, High- and Very High-Risk Pronostic Groups The International Prognostic Scoring System (IPSS), the WHO Prognostic Scoring System (WPSS), and the Revised-IPSS (IPSS-R) are the commonly used risk stratification systems for MDS ...